ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,892.16
-1.32%
Dow Jones
42,445.31
-1.27%
US Dollar vs MXN
20.50478
0.89%
Brent Oil
74.325
0.95%
Bitcoin
91,862.38
-1.77%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Genfit (GNFT) Cotización

Genfit

Genfit (GNFT)

Genfit SA
3.52
-0.01
( -0.28% )
Actualizado: 09:28:17
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
3.52
Postura de Compra
3.52
Postura de Venta
3.53
Volume Operado de la Acción
66,330
3.515 Rango del Día 3.575
3.025 Rango de 52 semanas 5.86
Capitalización de Mercado [m]
175.419M
Precio Anterior
3.53
Precio de Apertura
3.53
Hora
307
@
3.52
Última hora de negociación
09:43:52
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
269,307
Acciones en circulación
49,834,983
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-6.09
Beneficio por acción (BPA)
-0.58
turnover
38.68M
Beneficio neto
-28.89M

Acerca de Genfit

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.genfit.com
Sede
Loos, Nord, Fra
Fundado
-
Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 3.53 €. Over the last year, Genfit shares have traded in a share price range of 3.025 € to 5.86 €.

Genfit currently has 49,834,983 shares in issue. The market capitalisation of Genfit is 175.92 € million. Genfit has a price to earnings ratio (PE ratio) of -6.09.

GNFT Últimas noticias

Más noticias

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

13 Noviembre 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

13 Noviembre 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

13 Noviembre 2024
GlobeNewswire Inc.

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

07 Noviembre 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

07 Noviembre 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

07 Noviembre 2024
GlobeNewswire Inc.

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

23 Septiembre 2024
UK Regulatory

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

23 Septiembre 2024
UK Regulatory

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

23 Septiembre 2024
GlobeNewswire Inc.

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

19 Septiembre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.061.734104046243.463.5853.415911303.50371516DE
4-0.33-8.571428571433.853.8653.3851695093.60048113DE
12-1.32-27.27272727274.845.863.3852693074.71278332DE
26-0.015-0.42432814713.5355.863.3852439674.50567282DE
52-0.05-1.400560224093.575.863.0252510654.27545783DE
156-0.708-16.74550614954.2285.862.8041951323.90016817DE
260-14.99-80.983252296118.5120.962.7463048735.35503637DE

GNFT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Genfit?
El precio actual de las acciones de Genfit es 3.52 €
¿Cuántas acciones de Genfit están en circulación?
Genfit tiene 49,834,983 acciones en circulación
¿Cuál es la capitalización de mercado de Genfit?
La capitalización de mercado de Genfit es EUR 175.92M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Genfit?
Genfit ha negociado en un rango de 3.025 € a 5.86 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Genfit?
El ratio precio/beneficio de Genfit es -6.09
¿Cuál es el ratio de efectivo a ventas de Genfit?
El ratio de efectivo a ventas de Genfit es 4.55
¿Cuál es la moneda de reporte de Genfit?
Genfit presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Genfit?
El último ingresos anual de Genfit es EUR 38.68M
¿Cuál es el último beneficio anual de Genfit?
El último beneficio anual de Genfit es EUR -28.89M
¿Cuál es la dirección registrada de Genfit?
La dirección registrada de Genfit es PARC EURASANTE, 885 AVENUE EUGENE AVINEE, LOOS, NORD, 59120
¿Cuál es la dirección del sitio web de Genfit?
La dirección del sitio web de Genfit es www.genfit.com
¿En qué sector industrial opera Genfit?
Genfit opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALENREntreprendre
8.05 €
(54.81%)
91
MLOCTOctopus Biosafety
0.182 €
(45.60%)
34.73k
MLWEYWeya
0.0185 €
(37.04%)
1,000
CANDCandela Invest
1.46 €
(21.67%)
308
SECSoditech Ingeni
1.24 €
(19.23%)
530
EIFDSTour Eiffel DS
0.012 €
(-34.78%)
53.23k
MLFTIFrance Tourisme Immobilier
0.028 €
(-21.13%)
3.44k
PROACProactis SA
0.0525 €
(-20.45%)
5k
ALTROTronic s Microsystems
4.02 €
(-19.60%)
28
SEQUASequana medical NV
3.20 €
(-17.31%)
1.46M
ATOAtos SE
0.0027 €
(0.00%)
2.24B
ALCYBCybergun
0.0001 €
(0.00%)
45.84M
BCPBanco Comercial Portugues SA
0.4634 €
(0.70%)
36.78M
ALHPIHopium SA
0.0046 €
(-8.00%)
17.79M
BIOSBiosenic
0.0055 €
(-5.17%)
7.94M

Discusión

Ver feed completo
learningcurve2020 learningcurve2020 4 minutos hace
Can you imagine a shareholder class action where the judge realizes the complaint is about holding back a critical piece of information that’s ten years old! Get laughed right out of court. Can’t make it up.
NWBO
DaJester DaJester 4 minutos hace
Putting words in my mouth again, I see. I didn't say someone needs to file a lawsuit to invest. I said they need to file a lawsuit if they want a new and specific legal theory to be pursued, such as the supposedly illegality of the SPSPAs given language in those and the charters about fees.
FNMA
silvr_surfr silvr_surfr 4 minutos hace
Precedent aside, it does not make sense to have Chad there to say we can't talk about specific acquisition targets. There must be a completed deal that will be discussed. This fits with what has been going on the past many months.

In Mary's case, there was also the Cortrophin pre-cl
JPM
georgie18 georgie18 4 minutos hace
UAVS...$3.96...🥳...Volume starting to hit here...

georgie18

Member Level
Re: georgie18 post# 1519

Friday, December 27, 2024 2:17:52 PM

Post#
1520
of 1521
UAVS...$3.62...Added here...🥳Looking fo
UAVS
Clark6290 Clark6290 4 minutos hace
Lol, noted
FNMA
blackhawks blackhawks 4 minutos hace
Was featured on CBS special last night. It was outstanding

Relive the Grammy's most memorable moments with a new CBS special tonight

Christina Izzo

Sun, December 29, 2024 at 12:06 PM CST
2 min read

https://www.yahoo.com/entertainment
knrorrel knrorrel 4 minutos hace
$QGSI look at this unnoticed little quantum jewel that hasn't moved at all yet and this structure is uniquely small and for that reason alone it should easily move towards the dollar 🔥🔥🔥🔥🔥🔥🔥
imho

QGSI
EnchantedTitan62 EnchantedTitan62 4 minutos hace
Added 2,000 more, cost basis $2.98 for 4,900 shrs. I'm done, really, wife is yelling to me to start the car. Till next year 🍷
RR
georgie18 georgie18 4 minutos hace
UAVS...$3.96...🥳...Volume starting to hit here...

georgie18

Member Level
Re: georgie18 post# 1519

Friday, December 27, 2024 2:17:52 PM

Post#
1520
of 1521
UAVS...$3.62...Added here...🥳Looking fo
UAVS
PennyMillions852 PennyMillions852 4 minutos hace
Stuck at .0042
IGPK
georgie18 georgie18 4 minutos hace
UAVS...$3.96...🥳...Volume starting to hit here...

georgie18

Member Level
Re: georgie18 post# 1519

Friday, December 27, 2024 2:17:52 PM

Post#
1520
of 1521
UAVS...$3.62...Added here...🥳Looking fo
UAVS
harry crumb harry crumb 4 minutos hace
Never ever see 3$ again until the huge reverse split, coming soon lmao, trash company an trash stock an leadership! Chinese scammers
ILLR
manibiotech manibiotech 4 minutos hace
Well you can't blame the poor guy . Since the company doesn't give any PRs , he posts every other unrelated and irrelevant PR on the planet .
NWBO
Renee Renee 5 minutos hace
FLYLF: effective Dec. 31,2024 Firan Technology acquired all of the issued and outstanding common shares of Flyht by way of a plan of arrangement. Flyht shareholders were able to elect to receive, for each common share of Flyht held: (i) 11.03 cents in cash and 0.0333 Firan Technology share; (ii) 33.
FLYLF
Yooperman Yooperman 5 minutos hace
I don't think that was a copy.
https://www.facebook.com/tsoihome
TSOI
chsmoke chsmoke 5 minutos hace
nrdc. have a good 2025!
it won't matter what yves says, though i'd bet it'll be ambiguous. the believers will put a positive spin on,
the doubters and skeptics will see negatives, and the pps will stay in a range between 1.80 and 2.15.
there are scenarios where this could rise c
LWLG
LakeshoreLeo1953 LakeshoreLeo1953 5 minutos hace
Or you could be added to the permanent emoji auto response list.
Seems no matter how thoughtful or timely expressions of doubt arise
some just can't accept balanced thinking.
Not sure the Danish equivalent but..."A penny saved is a penny earned".

I'd be interested
AVXL
ANTI-BAGHOLDER ANTI-BAGHOLDER 5 minutos hace
Nice! They have created a new preferred class with no voting rights. When you listen back to the first or second spaces. Steve mentioned doing acquisitions and financing via preferred.

https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityNam
MONI
no_brag_just_fact no_brag_just_fact 5 minutos hace
Dreams of sugar plumbs no longer dances in my head.

NB
PHIL
glenn1919 glenn1919 5 minutos hace
cyn,,,,,,,,,,,,,,,,,,,,,,,https://stockcharts.com/h-sc/ui?s=cyn&p=W&b=5&g=0&id=p86431144783
CYN
work-n-hard work-n-hard 6 minutos hace
ONDS: Break over 3.08 may move back to HOD 3.39....3.76?
ONDS
trading.jeff trading.jeff 6 minutos hace
$OXY Uptrend intact, pps continuing to move up, despite the overall red in today's market.
OXY
ka ching ka ching 6 minutos hace
Damn I think Henry got me 😂 with his first tweet to me in over a year Might be a good deal that I have no money or might have lost more with his shenanigans of lieing and deception I can't believe he didn't get money again and NEXT WEEK AGAIN!!!! 😭
PHIL
jtaylor042 jtaylor042 6 minutos hace
No, parties can generally ask for a bench trial.
NWBO
ChannelTrader ChannelTrader 6 minutos hace
Watching Rav TV now...https://americasvoice.news/

Su Consulta Reciente

EU
GNFT
Genfit
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados